Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Yes thats all true. Patent law is complex | Investor2014 | investorshub | 03/16/2025 7:57:02 AM |
Nope, you should check the options open interest | crescentmotor | investorshub | 03/16/2025 2:57:16 AM |
You are not using the word "valid" correctly/appropriately | north40000 | investorshub | 03/16/2025 2:47:14 AM |
Nope, you should check the options open interest | B60611 | investorshub | 03/16/2025 2:06:39 AM |
Anavex has blarcamesine and A3-71. They will be | dia76ca | investorshub | 03/16/2025 2:02:04 AM |
Hi Lacey, yes more than puts. Puts | Hoskuld | investorshub | 03/15/2025 10:42:23 PM |
Please explain the hedge. This is more | Lacey1 | investorshub | 03/15/2025 10:32:14 PM |
Shorts are hedged so they have little to fear. | Hoskuld | investorshub | 03/15/2025 9:37:07 PM |
I posted that recent article because there was | Investor2014 | investorshub | 03/15/2025 8:07:35 PM |
I'm not going to put too much weight | boi568 | investorshub | 03/15/2025 5:20:37 PM |
boi, not really - the short position has | Hoskuld | investorshub | 03/15/2025 5:08:13 PM |
I've always been 50/50...I can't forecast the thoughts | IhidfromtheX | investorshub | 03/15/2025 4:44:18 PM |
https://www.medicandle.be/authors/laura-garcia-pupo-phd/ Thanks Guzzi62 | hnbadger1 | investorshub | 03/15/2025 3:28:30 PM |
Lol yes and the posts. | frrol | investorshub | 03/15/2025 3:18:05 PM |
PROTACs are an anti-plaque and anti-tangle approach similar | frrol | investorshub | 03/15/2025 3:15:59 PM |
Yes, it is difficult for charlatan fools to | catdaddy | investorshub | 03/15/2025 2:17:18 PM |
There is always the input of youth claiming | LakeshoreLeo1953 | investorshub | 03/15/2025 1:43:22 PM |
interesting approach to eg. AD treatment / prevention | Investor2014 | investorshub | 03/15/2025 12:59:41 PM |
A utility patent anywhere in the world, as | Investor2014 | investorshub | 03/15/2025 12:37:40 PM |
At least you are replying to your own | WolfofMia | investorshub | 03/15/2025 12:24:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
-1.56% G/L:
$9.43 Last:
902,271 Volume:
$9.14 Open:
$9.43 Close:
Anavex Life Sciences Corp. Website:
2025-03-04 10:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurod...
Citius Pharmaceuticals Inc. (CTXR) is expected to report $-1.25 for Q1 2025 Casio Computer Co Ltd ADR (CSIOY) is expected to report for Q3 2025 Dundee Precious Metals Inc. (DPMLF) is expected to report $0.45 for Q4 2024 Elite Pharmaceuticals, Inc. (ELTP) is expected to report for Q3 2...